Advertisement
TwistDx
TwistDx

Most Recent

image: Protein Spurs T-Cell Proliferation

Protein Spurs T-Cell Proliferation

By | April 17, 2015

A newly discovered protein promotes immunity to viruses and cancer by triggering the production of cytotoxic T cells.

1 Comment

image: Cancer Sequencing Controls

Cancer Sequencing Controls

By | April 15, 2015

Comparing a patient’s tumor DNA sequence with that of her normal tissue can improve researchers’ identification of disease-associated mutations.

1 Comment

image: Cannabidiol Quells Seizures

Cannabidiol Quells Seizures

By | April 14, 2015

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day.

0 Comments

image: Why DBS Works for Parkinson’s?

Why DBS Works for Parkinson’s?

By | April 14, 2015

Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex.

0 Comments

image: Cellular Garbage Disposal Illuminated

Cellular Garbage Disposal Illuminated

By | April 13, 2015

A Harvard team shows how cells label and recognize proteins for degradation.

0 Comments

image: 2015 Top 10 Innovations: Enter Today!

2015 Top 10 Innovations: Enter Today!

By | April 13, 2015

Submissions are officially open for this year’s Top 10 Innovations contest.

0 Comments

image: Ebola Vaccines Protect Monkeys

Ebola Vaccines Protect Monkeys

By | April 9, 2015

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.

0 Comments

image: A Benefit of Failed Pregnancy?

A Benefit of Failed Pregnancy?

By | April 9, 2015

Scientists find a common genetic variant in mothers that decreases the chance of successful pregnancy.

7 Comments

image: HIV Antibody Therapy

HIV Antibody Therapy

By | April 8, 2015

Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.

0 Comments

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.

2 Comments

Advertisement
RayBiotech
RayBiotech

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Eppendorf
Eppendorf
Advertisement
The Scientist